当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析

泰格医药

(300347)

  

流通市值:350.09亿  总市值:532.37亿
流通股本:5.66亿   总股本:8.61亿

泰格医药(300347)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.63亿元,每股收益0.45元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益2396370.24万元,未分配利润881544.19万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2850465.78万元,负债454095.54万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,250,444,279.631,564,143,614.716,603,120,162.785,067,615,359.89
营业总成本2,942,263,124.151,421,418,0035,610,048,004.894,026,550,519.06
其他经营收益
营业利润444,257,860.73144,504,382.4664,419,011.511,084,995,900.89
利润总额442,689,335.48143,625,342.84664,461,508.31,087,064,971.75
净利润362,828,303.84109,980,847.86447,831,286.97903,135,476.96
每股收益
其他综合收益48,983,183.825,329,777.35-30,367,462.62-50,709,884.36
综合收益总额411,811,487.66115,310,625.21417,463,824.35852,425,592.6
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计6,206,460,726.465,895,369,481.16,299,685,225.866,547,520,834.95
非流动资产:
非流动资产合计22,298,197,031.7522,834,223,468.1222,371,330,561.323,729,071,186.35
资产总计28,504,657,758.2128,729,592,949.2228,671,015,787.1630,276,592,021.3
流动负债:
流动负债合计3,395,689,292.773,635,724,221.913,661,852,465.124,795,257,756.83
非流动负债:
非流动负债合计1,145,266,109.011,185,258,688.81944,684,135.451,062,535,113.27
负债合计4,540,955,401.784,820,982,910.724,606,536,600.575,857,792,870.1
所有者权益(或股东权益):
归属于母公司股东权益合计20,524,441,879.1720,529,274,699.720,670,653,449.7221,064,966,698.75
股东权益合计23,963,702,356.4323,908,610,038.524,064,479,186.5924,418,799,151.2
负债和股东权益合计28,504,657,758.2128,729,592,949.2228,671,015,787.1630,276,592,021.3
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计3,422,805,826.471,652,480,592.316,960,762,922.994,993,719,526.64
经营活动现金流出小计3,014,186,818.531,454,545,978.135,863,761,019.254,414,949,916.69
经营活动产生的现金流量净额408,619,007.94197,934,614.181,097,001,903.74578,769,609.95
投资活动产生的现金流量:
投资活动现金流入小计1,058,992,171.79148,932,353.842,171,059,961.71667,411,884.05
投资活动现金流出小计1,013,102,115.39806,801,592.26,910,182,376.126,390,528,783.58
投资活动产生的现金流量净额45,890,056.4-657,869,238.36-4,739,122,414.41-5,723,116,899.53
筹资活动产生的现金流量:
筹资活动现金流入小计1,102,396,907.23617,956,0003,586,116,727.863,012,671,977.21
筹资活动现金流出小计1,929,347,228.17721,821,806.55,288,526,955.493,284,673,663.16
筹资活动产生的现金流量净额-826,950,320.94-103,865,806.5-1,702,410,227.63-272,001,685.95
汇率变动对现金及现金等价物的影响14,360,075.824,959,416.33-6,916,778.71-21,705,538.24
现金及现金等价物净增加额-358,081,180.78-558,841,014.35-5,351,447,517.01-5,438,054,513.77
期末现金及现金等价物余额1,690,412,672.061,489,652,838.492,048,493,852.841,961,886,856.08
补充资料:
现金及现金等价物的净增加额-358,081,180.78--5,351,447,517.01-
最新报告期:2025-09-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
财信证券吴号1.151.551.982025-09-01
光大证券叶思奥1.131.391.752025-08-31
中金公司张琎,吴婉桦1.161.38--2025-08-29
中信建投刘若飞,贺菊颖1.131.481.892025-07-08
中信证券陈竹,韩世通1.441.672.012025-07-04
TOP↑